High-throughput amplification fragment length polymorphism (htAFLP) analysis identifies genetic lineage markers but not complement phenotype-specific markers in Moraxella catarrhalis

Clinical Microbiology and Infection

Volumn 13, Issue 1, 2007, Pages 55-62

  Hays, J P ^a   Gorkink, R ^b   Simons, G ^b   Peeters, J K ^a   Eadie, K ^a   Verduin, C M ^c   Verbrugh, H ^a   Van Belkum, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b KEYGENE N V   (Netherlands)

^c Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

AFLP; Ccomplement resistance; Genetic lineage; Moraxella catarrhalis; Phylogenetic analysis; Polymorphisms

Indexed keywords

BACTERIAL PROTEIN; PROTEIN UBIQUITOUS SURFACE A2;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DNA SEQUENCE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOMIC FRAGMENT; HIGH THROUGHPUT SCREENING; MORAXELLA CATARRHALIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL;

MORAXELLA CATARRHALIS;

EID: 33845304724     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01582.x     Document Type: Article

References (38)

1. DiGiovanni C, Riley TV, Hoyne GF, Yeo R, Cooksey P. Respiratory tract infections due to Branhamella catarrhalis: Epidemiological data from western Australia. Epidemiol Infect 1987; 99: 445-453.
2. Faden H, Harabuchi Y, Hong JJ. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: Relationship to otitis media. J Infect Dis 1994; 169: 1312-1317.
3. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001; 20: 654-662.
4. Wald ER. The microbiology of chronic sinusitis in children. A review. Acta Otorhinolaryngol Belg 1997; 51: 51-54.
5. Claesson BA, Leinonen M. Moraxella catarrhalis -an uncommon cause of community-acquired pneumonia in Swedish children. Scand J Infect Dis 1994; 26: 399-402.
6. Abuhammour WM, Abdel-Haq NM, Asmar BI, Dajani AS. Moraxella catarrhalis bacteremia: A 10-year experience. South Med J 1999; 92: 1071-1074.
7. Ejlertsen T, Thisted E, Ebbesen F, Olesen B, Renneberg J. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J Infect 1994; 29: 23-31.
8. Prellner K, Christensen P, Hovelius B, Rosen C. Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. Acta Otolaryngol 1984; 98: 343-350.
9. Morgan MG, McKenzie H, Enright MC, Bain M, Emmanuel FX. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis 1992; 11: 305-312.
10. Hays JP, Eadie K, Verduin CM, Hazelzet J, Verbrugh H, van Belkum A. Changes in genetic types and population dynamics of Moraxella catarrhalis in hospitalized children are not associated with an exacerbation of existing disease. J Med Microbiol 2003; 52: 815-820.
11. Lieberman D, Ben-Yaakov M, Lazarovich Z et al. Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis 2001; 40: 95-102.
12. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465-471.
13. Lim WS, Macfarlane JT, Boswell TC et al. Study of community acquired pneumonia aetiology (scapa) in adults admitted to hospital: Implications for management guidelines. Thorax 2001; 56: 296-301.
14. Bootsma HJ, van Dijk H, Vauterin P, Verhoef J, Mooi FR. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: Evidence for transformation-mediated horizontal transfer. Mol Microbiol 2000; 36: 93-104.
15. Chaibi EB, Mugnier P, Kitzis MD, Goldstein FW, Acar JF. Beta-lactamases of Branhamella catarrhalis and their phenotypic implications. Res Microbiol 1995; 146: 761-771.
16. Verduin CM, Kools-Sijmons M, van der Plas J et al. Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species. FEMS Microbiol Lett 2000; 184: 1-8.
17. Bootsma HJ, van der Heide HG, van de Pas S, Schouls LM, Mooi FR. Analysis of Moraxella catarrhalis by DNA typing: Evidence for a distinct subpopulation associated with virulence traits. J Infect Dis 2000; 181: 1376-1387.
18. Hol C, Verduin CM, Van Dijke EE, Verhoef J, Fleer A, van Dijk H. Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis FEMS Immunol Med Microbiol 1995; 11: 207-211.
19. Hol C, Verduin CM, van Dijke E, Verhoef J, van Dijk H. Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet 1993; 341: 1281.
20. Nordstrom T, Blom AM, Forsgren A, Riesbeck K. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor c4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol 2004; 173: 4598-4606.
21. Verduin CM, Jansze M, Verhoef J, Fleer A, van Dijk H. Complement resistance in Moraxella (Branhamella) catarrhalis is mediated by a vitronectin-binding surface protein. Clin Exp Immunol 1994; 97: 50.
22. Aebi C, Lafontaine ER, Cope LD et al. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035e. Infect Immun 1998; 66: 3113-3119.
23. McMichael JC, Fiske MJ, Fredenburg RA et al. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun 1998; 66: 4374-4381.
24. Attia AS, Lafontaine ER, Latimer JL, Aebi C, Syrogiannopoulos GA, Hansen EJ. The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infect Immun 2005; 73: 2400-2410.
25. Nordstrom T, Blom AM, Tan TT, Forsgren A, Riesbeck K. Ionic binding of c3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity. J Immunol 2005; 175: 3628-3636.
26. Helminen ME, Maciver I, Paris M et al. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis 1993; 168: 1194-1201.
27. Aebi C, Stone B, Beucher M et al. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect Immun 1996; 64: 2024-2030.
28. Murphy TF, Brauer AL, Yuskiw N, Hiltke TJ. Antigenic structure of outer membrane protein ε of Moraxella catarrhalis and construction and characterization of mutants. Infect Immun 2000; 68: 6250-6256.
29. Zaleski A, Scheffler NK, Densen P et al. Lipooligosaccharide p(k) (galalpha1-4galbeta1-4glc) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum. Infect Immun 2000; 68: 5261-5268.
30. Furano K, Campagnari AA. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera. Infect Immun 2003; 71: 1843-1848.
31. Enright MC, McKenzie H. Moraxella (Branhamella) catarrhalis - clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol 1997; 46: 360-371.
32. Wolf B, Kools-Sijmons M, Verduin C et al. Genetic diversity among strains of Moraxella catarrhalis cultured from the nasopharynx of young and healthy Brazilian, Angolan and Dutch children. Eur J Clin Microbiol Infect Dis 2000; 19: 759-764.
33. Verduin CM, Hol C, Van Dijke E et al. Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method. Clin Diagn Lab Immunol 1995; 2: 365-368.
34. Vos P, Hogers R, Bleeker M et al. AFLP. A new technique for DNA fingerprinting. Nucl Acids Res 1995; 23: 4407-4414.
35. Hays JP, van Selm S, Hoogenboezem T et al. Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms. J Bacteriol 2005; 187: 7977-7984.
36. Bonnah RA, Yu RH, Wong H, Schryvers AB. Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis. Microb Pathog 1998; 24: 89-100.
37. Helminen ME, Maciver I, Latimer JL, Cope LD, McCracken GH, Hansen EJ. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun 1993; 61: 2003-2010.
38. Lafontaine ER, Cope LD, Aebi C, Latimer JL, McCracken GH, Hansen EJ. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol 2000; 182: 1364-1373.